Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
4.400
+0.520 (13.40%)
Nov 4, 2024, 4:00 PM EST - Market closed
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.56 billion as of November 4, 2024. Its market cap has decreased by -51.83% in one year.
Market Cap
1.56B
Enterprise Value
1.75B
1-Year Change
-51.83%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since the IPO on February 5, 2015, Evotec SE's market cap has increased from $464.70M to $1.56B, an increase of 236.47%. That is a compound annual growth rate of 13.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 1, 2024 | 1.38B | -66.92% |
Dec 29, 2023 | 4.16B | 45.19% |
Dec 30, 2022 | 2.86B | -65.68% |
Dec 31, 2021 | 8.34B | 108.85% |
Dec 31, 2020 | 3.99B | 42.78% |
Dec 31, 2019 | 2.80B | 29.06% |
Dec 31, 2018 | 2.17B | 24.07% |
Dec 29, 2017 | 1.75B | 106.15% |
Dec 30, 2016 | 847.40M | 72.48% |
Dec 31, 2015 | 491.30M | 5.72% |
Feb 5, 2015 | 464.70M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ardelyx | 1.44B |
Arcus Biosciences | 1.42B |
STAAR Surgical Company | 1.41B |
AMN Healthcare Services | 1.40B |
Disc Medicine | 1.40B |
Travere Therapeutics | 1.37B |
AdaptHealth | 1.37B |
Progyny | 1.35B |